Dubois DR - Search Results

1

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.

Putnak R, Barvir DA, Burrous JM, Dubois DR, D'Andrea VM, Hoke CH, Sadoff JC, Eckels KH. Putnak R, et al. Among authors: dubois dr. J Infect Dis. 1996 Dec;174(6):1176-84. doi: 10.1093/infdis/174.6.1176. J Infect Dis. 1996. PMID: 8940206

2

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

Eckels KH, Dubois DR, Putnak R, Vaughn DW, Innis BL, Henchal EA, Hoke CH Jr. Eckels KH, et al. Among authors: dubois dr. Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):12-6. doi: 10.4269/ajtmh.2003.69.12. Am J Trop Med Hyg. 2003. PMID: 14740950

3

Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells.

Putnak R, Cassidy K, Conforti N, Lee R, Sollazzo D, Truong T, Ing E, Dubois D, Sparkuhl J, Gastle W, Hoke C. Putnak R, et al. Am J Trop Med Hyg. 1996 Nov;55(5):504-10. doi: 10.4269/ajtmh.1996.55.504. Am J Trop Med Hyg. 1996. PMID: 8940981

4

Large-scale purification of inactivated hepatitis A virus by centrifugation in non-ionic gradients.

Dubois DR, Eckels KH, Ticehurst J, Binn LN, Timchak RL, Barvir DA, Rankin CT, O'Neill SP. Dubois DR, et al. J Virol Methods. 1991 May;32(2-3):327-34. doi: 10.1016/0166-0934(91)90062-5. J Virol Methods. 1991. PMID: 1651954

5

Immunogenicity of an inactivated hepatitis A vaccine.

Sjogren MH, Hoke CH, Binn LN, Eckels KH, Dubois DR, Lyde L, Tsuchida A, Oaks S Jr, Marchwicki R, Lednar W, et al. Sjogren MH, et al. Among authors: dubois dr. Ann Intern Med. 1991 Mar 15;114(6):470-1. doi: 10.7326/0003-4819-114-6-470. Ann Intern Med. 1991. PMID: 1994794 Clinical Trial. No abstract available.

6

Expression of the envelope antigen of dengue virus in vaccine strains of Salmonella.

Cohen S, Powell CJ, Dubois DR, Hartman A, Summers PL, Eckels KH. Cohen S, et al. Among authors: dubois dr. Res Microbiol. 1990 Sep-Oct;141(7-8):855-8. doi: 10.1016/0923-2508(90)90121-6. Res Microbiol. 1990. PMID: 2101475 Free article.

7

Preparation of noninfectious hepatitis A virus hemagglutinin for detecting hemagglutination inhibition antibodies.

Dubois DR, Binn LN, Summers PL, Timchak RL, Barvir DA, Marchwicki RH, Eckels KH. Dubois DR, et al. J Virol Methods. 1990 Jun;28(3):299-304. doi: 10.1016/0166-0934(90)90123-w. J Virol Methods. 1990. PMID: 2166750

8

Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans.

Hoke CH Jr, Malinoski FJ, Eckels KH, Scott RM, Dubois DR, Summers PL, Simms T, Burrous J, Hasty SE, Bancroft WH. Hoke CH Jr, et al. Among authors: dubois dr. Am J Trop Med Hyg. 1990 Aug;43(2):219-26. doi: 10.4269/ajtmh.1990.43.219. Am J Trop Med Hyg. 1990. PMID: 2389825

9

Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation.

Innis BL, Eckels KH, Kraiselburd E, Dubois DR, Meadors GF, Gubler DJ, Burke DS, Bancroft WH. Innis BL, et al. Among authors: dubois dr. J Infect Dis. 1988 Oct;158(4):876-80. doi: 10.1093/infdis/158.4.876. J Infect Dis. 1988. PMID: 3171230 No abstract available.

10

Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers.

Bancroft WH, Scott RM, Eckels KH, Hoke CH Jr, Simms TE, Jesrani KD, Summers PL, Dubois DR, Tsoulos D, Russell PK. Bancroft WH, et al. Among authors: dubois dr. J Infect Dis. 1984 Jun;149(6):1005-10. doi: 10.1093/infdis/149.6.1005. J Infect Dis. 1984. PMID: 6376649 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page